157 related articles for article (PubMed ID: 15820757)
1. Synthesis and in vitro and in vivo evaluation of three radioiodinated nitroimidazole analogues as tumor hypoxia markers.
Li Z; Chu T; Liu X; Wang X
Nucl Med Biol; 2005 Apr; 32(3):225-31. PubMed ID: 15820757
[TBL] [Abstract][Full Text] [Related]
2. Preparation and biodistribution of technetium-99m-labeled 1-(2-nitroimidazole-1-yl)-propanhydroxyiminoamide (N2IPA) as a tumor hypoxia marker.
Chu T; Li R; Hu S; Liu X; Wang X
Nucl Med Biol; 2004 Feb; 31(2):199-203. PubMed ID: 15013485
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of radioiodinated 2NUBTA as a cerebral ischemia marker.
Chu T; Li Z; Wang X
Bioorg Med Chem Lett; 2009 Feb; 19(3):658-61. PubMed ID: 19121583
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF
Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
[TBL] [Abstract][Full Text] [Related]
8. Radiosynthesis and evaluation of two novel 123I-labeled 2-methyl-4-nitroimidazole derivatives as potential infection imaging agents.
Rossouw DD; Lötter MG; du Raan H; Jansen SE; Höhn A; Burger BV
Nucl Med Biol; 2005 May; 32(4):385-94. PubMed ID: 15878508
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of (131/123)I-5-iodo-2'-deoxycytidine as a novel proliferation probe in a tumor mouse model.
Chang WY; Kuo WT; Wu CY; Lin CY; Chan PC; Shen CC; Liu RS; Wang HE; Chen CL
Appl Radiat Isot; 2013 Jul; 77():166-73. PubMed ID: 23602704
[TBL] [Abstract][Full Text] [Related]
10. New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents.
Oltenfreiter R; Staelens L; Lejeune A; Dumont F; Frankenne F; Foidart JM; Slegers G
Nucl Med Biol; 2004 May; 31(4):459-68. PubMed ID: 15093816
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
12. Preclinical assessment of hypoxic marker specificity and sensitivity.
Iyer RV; Engelhardt EL; Stobbe CC; Schneider RF; Chapman JD
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):741-5. PubMed ID: 9845088
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and bioevaluation of radioiodinated nitroimidazole hypoxia imaging agents by one-pot click reaction.
Yang R; Wang D; Chu T
Bioorg Med Chem Lett; 2020 Sep; 30(17):127386. PubMed ID: 32738994
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia.
Chu T; Hu S; Wei B; Wang Y; Liu X; Wang X
Bioorg Med Chem Lett; 2004 Feb; 14(3):747-9. PubMed ID: 14741282
[TBL] [Abstract][Full Text] [Related]
15. Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.
Huang H; Zhou H; Li Z; Wang X; Chu T
Bioorg Med Chem Lett; 2012 Jan; 22(1):172-7. PubMed ID: 22153341
[TBL] [Abstract][Full Text] [Related]
16. The synthesis and radiolabeling of 2-nitroimidazole derivatives of cyclam and their preclinical evaluation as positive markers of tumor hypoxia.
Engelhardt EL; Schneider RF; Seeholzer SH; Stobbe CC; Chapman JD
J Nucl Med; 2002 Jun; 43(6):837-50. PubMed ID: 12050331
[TBL] [Abstract][Full Text] [Related]
17. Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia.
Mannan RH; Somayaji VV; Lee J; Mercer JR; Chapman JD; Wiebe LI
J Nucl Med; 1991 Sep; 32(9):1764-70. PubMed ID: 1880579
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of the nitroimidazole-based thioflavin-T derivatives as cerebral ischemia markers.
Chu T; Li Z; Liu X; Wang X
Int J Biomed Imaging; 2007; 2007():49791. PubMed ID: 18350127
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers.
Hoigebazar L; Jeong JM; Hong MK; Kim YJ; Lee JY; Shetty D; Lee YS; Lee DS; Chung JK; Lee MC
Bioorg Med Chem; 2011 Apr; 19(7):2176-81. PubMed ID: 21419635
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of [
Ruan Q; Zhang X; Gan Q; Fang S; Zhang J
Bioorg Med Chem Lett; 2020 Nov; 30(22):127582. PubMed ID: 33002601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
